Yu‐Hsien Chen - Concepedia

Author

Yu‐Hsien Chen

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Y T Chen, Y. T. Chen, Yao Chi Chen, Yu-Hsien Chen, Yu‐Hsien Chen

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Ludwig Cancer Research Scripps Research Institute

About

Yu‐Hsien Chen is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cancer research, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	964
2	Cell Biology	5	5	668
3	Engineering	1	1	134
4	Natural Sciences	1	1	26
5	Biochemistry	1	1	26

Yu‐Hsien Chen

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Matthew J. Scanlan, Ivan Gout, Claudia Gordon, PubMed Breast Cancer AntigensBreast OncologyHumoral ResponseImmunologyImmune Regulation	2001	184
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Yu‐Hsien Chen, Elisabeth Stockert, Solam Tsang, Proceedings of the National Academy of Sciences Immunocytochemical TechniqueImmunologyImmunoeditingPathologyAntigen Processing	1995	181
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells. Yuji Noguchi, Yu‐Hsien Chen, Lloyd J. Old Proceedings of the National Academy of Sciences Cancer ImmunosurveillanceOncogenic AgentMedicineCorresponding PeptidesImmunology	1994	172
Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Dirk Jäger, Elisabeth Stockert, Ali O. Güre, PubMed Breast OncologyEngineeringPathologyGene Expression ProfilingTumor Biology	2001	134
Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Dirk Jäger, Elisabeth Stockert, Matthew J. Scanlan, PubMed Breast Cancer AntigensBreast OncologyPathologyCancer BiologyTumor Biology	1999	114
Substrate Specificity Profiling and Identification of a New Class of Inhibitor for the Major Protease of the SARS Coronavirus<sup>,</sup> David H. Goetz, Y. Choe, Elizabeth Hansell, Biochemistry	2007	105
Cancer-testis antigens: targets for cancer immunotherapy. Yu‐Hsien Chen, L. J. Old PubMed Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint Inhibitor	1999	76
5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors. Pramod K. Srivastava, Yu‐Hsien Chen, Lloyd J. Old Proceedings of the National Academy of Sciences Gp96 GeneMr 96,000ImmunologyMolecular BiologyPathology	1987	67
Synthesis of <scp>l</scp>-ascorbic acid in rat-liver homogenates: conversion of <scp>l</scp>-gulono- and <scp>l</scp>-galactono-γ-lactone and the respective acids into <scp>l</scp>-ascorbic acid F. A. Isherwood, Y. W. Mapson, Yu‐Hsien Chen Biochemical Journal	1960	44
Tetrabutylammonium Fluoride‐Mediated Rapid Alkylation Reaction in Microtiter Plates for the Discovery of Enzyme Inhibitors in Situ Chung‐Yi Wu, Ashraf Brik, Sheng‐Kai Wang, ChemBioChem Microtiter PlatesProtein ChemistryMedicinal ChemistryBiochemistryHiv Protease	2005	26

Page 1